Nifenalol (hydrochloride)
Nifenalol hydrochloride is a β-adrenergic receptor antagonist. Nifenalol hydrochloride induces the Early Afterdepolarization (EAD) effect. EAD is a phenomenon in cardiac electrophysiology that usually occurs during an action potential in ventricular muscle cells and can lead to arrhythmia. The EAD effect of Nifenalol hydrochloride can be blocked by Tetrodotoxin. Nifenalol hydrochloride is used in the study of conditions such as irregular heartbeat or high blood pressure[1].
Product Specifications
CAS Number
[5704-60-9]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Adrenergic Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/nifenalol-hydrochloride.html
Purity
99.93
Solubility
DMSO : 250 mg/mL (ultrasonic) |H2O : 50 mg/mL (ultrasonic)
Smiles
OC(CNC(C)C)C1=CC=C([N+]([O-])=O)C=C1.[H]Cl
Molecular Formula
C11H17ClN2O3
Molecular Weight
260.72
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
β adrenergic receptor
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NOD2 (Nucleotide-binding Oligomerization Domain-containing Protein 2, Caspase Recruitment Domain-containing Protein 15, Inflammatory Bowel Disease Protein 1, CARD15, IBD1, ACUG, BLAU, NLRC2, NOD2B, CLR16.3, PSORAS1) discontinued